These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9601665)
1. Bcl-2 and Bax protein expression in neurofibrillary tangles in progressive supranuclear palsy. Tortosa A; Blanco R; Ferrer I Neuroreport; 1998 Apr; 9(6):1049-52. PubMed ID: 9601665 [TBL] [Abstract][Full Text] [Related]
2. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. Su JH; Deng G; Cotman CW J Neuropathol Exp Neurol; 1997 Jan; 56(1):86-93. PubMed ID: 8990132 [TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and Bax protein expression in Alzheimer's disease. Tortosa A; López E; Ferrer I Acta Neuropathol; 1998 Apr; 95(4):407-12. PubMed ID: 9560019 [TBL] [Abstract][Full Text] [Related]
4. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576 [TBL] [Abstract][Full Text] [Related]
5. Aberrant accumulation of ErbB4 in progressive supranuclear palsy. Murakami A; Nakamura M; Kaneko S; Lin WL; Dickson DW; Kusaka H Neuropathol Appl Neurobiol; 2018 Oct; 44(6):563-573. PubMed ID: 29319907 [TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344 [TBL] [Abstract][Full Text] [Related]
8. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Henderson JM; Carpenter K; Cartwright H; Halliday GM Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Nishimura T; Ikeda K; Akiyama H; Kondo H; Kato M; Li F; Iseki E; Kosaka K Neurosci Lett; 1995 Dec; 201(2):123-6. PubMed ID: 8848233 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
12. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Togo T; Dickson DW Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627 [TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles in the neurons of spinal dorsal root ganglia of patients with progressive supranuclear palsy. Nishimura M; Namba Y; Ikeda K; Akiguchi I; Oda M Acta Neuropathol; 1993; 85(5):453-7. PubMed ID: 8388145 [TBL] [Abstract][Full Text] [Related]
14. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815 [TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein. Fergusson J; Landon M; Lowe J; Ward L; van Leeuwen FW; Mayer RJ Neurosci Lett; 2000 Jan; 279(2):69-72. PubMed ID: 10674623 [TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary pathology in progressive supranuclear palsy (PSP). Cervós-Navarro J; Schumacher K J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685 [TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Nishimura M; Namba Y; Ikeda K; Oda M Neurosci Lett; 1992 Aug; 143(1-2):35-8. PubMed ID: 1436679 [TBL] [Abstract][Full Text] [Related]
18. Relationship between neuronal loss and tangle formation in neurons and oligodendroglia in progressive supranuclear palsy. Jin C; Katayama S; Hiji M; Watanabe C; Noda K; Nakamura S; Matsumoto M Neuropathology; 2006 Feb; 26(1):50-6. PubMed ID: 16521479 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia. Kida E; Barcikowska M; Niemczewska M Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]